Collaboration to Improve Early Blood Cancer Detection and Treatment

Juntendo University, Sysmex Corporation, and ThinkCyte K.K. have announced a collaborative research partnership to advance the early detection and treatmen...

April 19, 2023 | Wednesday | News
FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

"Today's approval is an important advance in cell therapy treatment in patients with blood cancers," said Peter Marks, M.D., Ph.D., director of the FDA's C...

April 18, 2023 | Tuesday | News
Xyall and Indica Labs collaborate to transform precision oncology workflows

Bridging the gap between histopathology and molecular pathology Xyall and Indica Labs have entered into a global strategic partnership designed to bridge ...

April 18, 2023 | Tuesday | News
Scientists from Singapore & Sweden makes progress in restoring vision lost to cellular degeneration

 A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the eye—and then transplant...

April 17, 2023 | Monday | News
Agena Bioscience and nRichDX Partner for Liquid Biopsy Analyte Extraction and Detection Solutions

Agena Bioscience and nRichDX have advanced their existing technical collaboration to a commercial partnership that co-promotes their products to researcher...

April 17, 2023 | Monday | News
QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced the launch of QIAseq Targeted cfDNA Ultra Panels that will enable researchers studying cancer ...

April 17, 2023 | Monday | News
Daon to Bring Trusted Identity Proofing and Authentication Solutions to Healthcare Industry

Daon, the Digital Identity Trust company, is expanding its identity proofing and authentication solutions to the healthcare industry to enable organization...

April 14, 2023 | Friday | News
Initiation of New Patients on Evobrutinib Paused in the U.S.; Fully Enrolled Phase III Evobrutinib Studies Continue

Merck, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the init...

April 14, 2023 | Friday | News
ClearPoint Neuro extends agreement with Philips to include automatic subnuclei segmentation for DBS

The design goal of the ClearPoint Maestro® Brain Model is to enable highly accurate ClearPoint interventions under both MRI and CT guidance by facilit...

April 12, 2023 | Wednesday | News
Hillstream BioPharma Announces Pharmacokinetic Data of HSB-1216 Supportive of its Development Strategy and Pre-clinical Data

Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology company developing a portfolio of therapeutic candidates targeti...

April 11, 2023 | Tuesday | News
ZSFab Announces Second Clinical Use of the ZSFab Cervical Interbody System for ACDF

Dr. Moore performed a 3-level ACDF procedure with theZSFab Cervical Interbody System at The Surgical Hospital of Oklahoma. This was the second case in...

April 11, 2023 | Tuesday | News
Calyx Delivers Imaging Biomarkers to Advance Neuropsychiatric Treatment Development

Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data challenges in clinical research,  announced a s...

April 10, 2023 | Monday | News
Mercy BioAnalytics Raises $41M to Advance Mercy Halo Liquid Biopsy for Cancer Detection

The oversubscribed financing was led by Novalis LifeSciences, with participation from Sozo Ventures, Hatteras Venture Partners, iSelect Fund, American Canc...

April 04, 2023 | Tuesday | News
Medtronic and DaVita launch Mozarc Medical for kidney failure solutions

Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA) announced the launch of Mozarc Medical—an independent new company committed to reshap...

April 02, 2023 | Sunday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close